Concept Life Sciences has appointed Dr Adam Davenport as chief scientific officer as it looks to strengthen its integrated drug discovery offering.

Davenport brings more than 25 years of experience across drug discovery and partnership-led R&D, having most recently served as chief discovery officer at Proxygen and previously held senior roles at Dalriada Drug Discovery and Evotec.

The appointment comes during a period of growth for the Chapel-en-le-Frith-based firm, as it continues to expand its discovery facilities and support global clients.